A Single Dose Study of MK-6194 in Healthy Chinese Participants (MK-6194-014)

A Randomized, Double-Blind, Placebo-Controlled Single Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics of MK-6194 in Healthy Chinese Participants

The goal of this study is to learn how safe MK-6194 is in healthy Chinese adults and how well people tolerate it.

Inclusion Criteria:

The key inclusion criteria include but are not limited to the following:

• Is in good health
• Has body mass index (BMI) within 18.0 to 28.0 kg/m^2 (inclusive) and weight ≥50 kg

Exclusion Criteria:

The key exclusion criteria include but are not limited to the following:

• History of clinically significant endocrine, gastrointestinal (GI), cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological (including stroke and chronic seizures) abnormalities or diseases
• Has a history of opportunistic infection, Human immunodeficiency virus (HIV), hepatitis B, hepatitis C, tuberculosis